RenovoRx annual operating expenses
2020
2021
2022
2023
2024
2025
RenovoRx Operating Expenses Growth & History (RNXT)
RenovoRx's operating expenses was $13.3M for fiscal 2025.
View full RenovoRx company overviewRenovoRx annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.3M | $2.3M | +20.82% |
| 2024 | 2024-12-31 | $11.0M | −$383,000 | −3.36% |
| 2023 | 2023-12-31 | $11.4M | $1.4M | +14.53% |
| 2022 | 2022-12-31 | $9.9M | $4.3M | +75.45% |
| 2021 | 2021-12-31 | $5.7M | $2.5M | +77.00% |
| 2020 | 2020-12-31 | $3.2M | — | — |
RenovoRx quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.1M | $1.2M | +39.59% |
| Q1 2026 | 2026-03-31 | $3.9M | $735,000 | +22.88% |
| Q4 2025 | 2025-12-31 | $3.7M | $1.1M | +39.51% |
| Q3 2025 | 2025-09-30 | $3.4M | $585,000 | +20.69% |
| Q2 2025 | 2025-06-30 | $2.9M | −$86,000 | −2.83% |
| Q1 2025 | 2025-03-31 | $3.2M | $737,000 | +29.77% |
| Q4 2024 | 2024-12-31 | $2.7M | $898,000 | +50.53% |
| Q3 2024 | 2024-09-30 | $2.8M | −$155,000 | −5.20% |
| Q2 2024 | 2024-06-30 | $3.0M | −$341,000 | −10.10% |
| Q1 2024 | 2024-03-31 | $2.5M | −$785,000 | −24.07% |
| Q4 2023 | 2023-12-31 | $1.8M | −$393,000 | −18.11% |
| Q3 2023 | 2023-09-30 | $3.0M | $822,000 | +38.04% |
| Q2 2023 | 2023-06-30 | $3.4M | $761,000 | +29.11% |
| Q1 2023 | 2023-03-31 | $3.3M | $256,000 | +8.52% |
| Q4 2022 | 2022-12-31 | $2.2M | −$187,000 | −7.93% |
| Q3 2022 | 2022-09-30 | $2.2M | $766,000 | +54.91% |
| Q2 2022 | 2022-06-30 | $2.6M | $1.7M | +201.85% |
| Q1 2022 | 2022-03-31 | $3.0M | $2.0M | +185.38% |
| Q4 2021 | 2021-12-31 | $2.4M | — | — |
| Q3 2021 | 2021-09-30 | $1.4M | $485,000 | +53.30% |
| Q2 2021 | 2021-06-30 | $866,000 | — | — |
| Q1 2021 | 2021-03-31 | $1.1M | — | — |
| Q3 2020 | 2020-09-30 | $910,000 | — | — |
RenovoRx operating expenses trends
Over the last five fiscal years, RenovoRx's operating expenses increased from $3.2M to $13.3M, a change of $10.1M. The latest reported quarter, Q2 2026, shows $4.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RenovoRx source filings ↗